Prolyl endopeptidase inhibitors in neutrophilic lung inflammation in mice

Keyphrases

• Proline 100%
• Neutrophilic Inflammation 100%
• Prolyl Oligopeptidase Inhibitor 100%
• Prolyl Oligopeptidase 100%
• Collagen 66%
• Bronchoalveolar Lavage Fluid 66%
• Chronic Obstructive Pulmonary Disease 33%
• Neutrophils 33%
• Specific Inhibitor 33%
• Tripeptide 33%
• Consecutive Days 33%
• Twice Daily 33%
• Cell Count 33%
• Cigarette Smoking 33%
• Cystic Fibrosis 33%
• Whole-body 33%
• Lung Disease 33%
• Neutrophilia 33%
• Total Cell Count 33%
• Enzymatic Cascade 33%
• Bonferroni Test 33%
• One-way ANOVA Test 33%
• KYP-2047 33%

Medicine and Dentistry

• Pneumonia 100%
• Proline 100%
• Prolyl Endopeptidase Inhibitor 100%
• Prolyl Endopeptidase 100%
• Cell Count 66%
• Bronchoalveolar Lavage Fluid 66%
• Chronic Obstructive Pulmonary Disease 33%
• Cigarette Smoke 33%
• Cystic Fibrosis 33%
• Neutrophilia 33%
• Analysis of Variance 33%
• Metabolite 33%
• Dexamethasone 33%
• Dimethyl Sulfoxide 33%
• Tripeptide 33%
• Neutrophil 33%
• Chemotherapy 33%
• Pulmonary Disorder 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Prolyl Endopeptidase 100%
• Prolyl Endopeptidase Inhibitor 100%
• Proline 100%
• Pneumonia 100%
• Chemotherapy 33%
• Chronic Obstructive Lung Disease 33%
• Dimethyl Sulfoxide 33%
• Cigarette Smoke 33%
• Cystic Fibrosis 33%
• Neutrophilia 33%
• Dexamethasone 33%
• Tripeptide 33%
• Diseases 33%